Rajagopal Varada, Alina F Leuchtenberger, Cornelia Vesely, Beata Kaczmarek, Hamid Mansouri Khosravi, Therese C Mandl, Katarina Milanovic, Kasra Honarmand Tamizkar, Vinod Rajendra, Hannes Senoner, Linda Steinbichl, Marija Borojevic, Andy Sombke, Katy Schmidt, Margret Eckhard, Ivo L Hofacker, Carl Walkley, Jacki E Heraud-Farlow, Ernesto Picardi, Carrie Bernecky, Michael F Jantsch
The cytoplasmic antiviral sensor MDA5 is activated by double-stranded RNAs. Endogenous double-stranded RNAs are modified by the A-to-I RNA-editing ADAR family to prevent activation of MDA5. In vivo, cytoplasmic ADAR1p150 is critically required to suppress MDA5 activation, yet the editing signature of all ADAR isoforms is strongly overlapping in mice. Further, it is not clear how A-to-I modifications in dsRNA prevent MDA5 activation. Here we show that 3' UTRs harboring inverted repeats activate MDA5 in vitro and in cells. In vitro editing by either ADAR isoform leads to editing at overlapping hotspot regions and prevents MDA5 activation in vitro and in cells. Remarkably, only inosines introduced by RNA editing are capable of suppressing MDA5 activation, while replacing guanosines with inosines during in vitro transcription has no impact on MDA5 activation. A comparison of inosines introduced by ADAR1p150 in vitro, in cells, and in vivo suggests that a small number of A-to-I conversions may be critically required to suppress MDA5 activation. As those critical editing events are predominantly altering A:U basepairs into I:U wobble basepairs, we suggest that the helical distortion introduced by those wobble pairs may prevent MDA5 polymerization and thus downstream activation of the type I interferon response.